PURPOSE: To evaluate the anatomic and visual outcomes of patients treated with triamcinolone acetonide (TA) assisted internal membrane peeling for idiopathic full-thickness macular holes.


PURPOSE: To evaluate the anatomic and visual outcomes of patients treated with triamcinolone acetonide (TA) assisted internal membrane peeling for idiopathic full-thickness macular holes.